Hjem › Crohns sykdom › Rhode Island › Providence
Kliniske studier for Crohns sykdom i Providence, RI
12 studier for Crohns sykdom søker deltakere på steder i og rundt Providence (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
RekruttererFase 3
- University Gastroenterology - Providence - West River Street ( Site 5057), Providence
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
RekruttererFase 2
- University Gastroenterology - Providence - Staniford Street /ID# 280919, Providence
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
RekruttererFase 4
- University Gastroenterology, Providence
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
RekruttererFase 2/3
- University Gastroenterology, Providence
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
RekruttererFase 2
- University Gastroenterology Providence, Providence
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
RekruttererFase 3
- University Gastroenterology, Providence
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
RekruttererFase 3
- University Gastroenterology-Site Number: 8400103, Providence
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
RekruttererFase 3
- University Gastroenterology - GI Alliance-Site Number: 8400103, Providence
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
RekruttererFase 4
- University Gastroenterology, Providence
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
Rekrutterer
- Gastroenterology Associates, Providence
Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
RekruttererFase 4
- Rhode Island Hospital, Providence
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
RekruttererFase 2
- Mirador Therapeutics Selected Site, Providence
Crohns sykdom-studier i andre byer
- New York City, NY35 studier
- Cleveland, OH19 studier
- St. Louis, MO19 studier
- Boston, MA19 studier
- Miami, FL19 studier
- Orlando, FL17 studier
- Houston, TX17 studier
- Atlanta, GA17 studier
- Tyler, TX16 studier
- San Diego, CA15 studier
- San Antonio, TX15 studier
- Los Angeles, CA15 studier
Andre studier i Providence
- Eggstokkreft15 studier
- Endometriekreft14 studier
- Fedme14 studier
- Ikke-småcellet lungekreft12 studier
- Kreft (alle typer)12 studier
- Ulcerøs kolitt11 studier
- Brystkreft11 studier
- Akut myelogen leukemi10 studier
- Metastatisk kreft9 studier
- Overvekt9 studier
- Alzheimers sykdom8 studier
- Alkoholbrukforstyrrelse (AUD)8 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.